School of Medicine
Showing 1-20 of 78 Results
-
Holly Tabor
Associate Professor of Medicine (General Medical Disciplines) and, by courtesy, of Epidemiology and Population Health at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
-
Manjula Kurella Tamura
Professor of Medicine (Nephrology) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests I am a clinical and health services investigator whose primary interest is in improving the quality of end-stage renal disease (ESRD) care among older adults. My previous and current work aims to describe outcomes (especially geriatric outcomes) in older patients and to compare the effectiveness of different ESRD management strategies on these outcomes.
-
Jane C. Tan
Professor of Medicine (Nephrology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research relates to issues pertaining to clinical kidney transplantation. We have ongoing studies on the following topics.
1. Renal senescence and kidney transplant, and chronic allograft nephropathy.
2. Living donor safety and response to uninephrectomy.
3. Biomarkers for post-transplant monitoring. -
Marilyn Tan
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly Interests Type 2 diabetes, obesity, insulin resistance
-
Branden Tarlow
Postdoctoral Medical Fellow, Gastroenterology
Current Research and Scholarly Interests Physician scientist interested in liver regeneration, cell therapy, and cancer
-
(Nicholas) Kenji Taylor
Instructor, Medicine - Primary Care and Population Health
Bio Dr. Taylor was born and raised in rural Kansas and Pennsylvania, the youngest of four children. He headed to the big city of Providence, RI to study Neuroscience, East Asian Studies and Entrepreneurship at Brown University. Following graduation, his short-lived career in finance took him to Los Angeles, London and Tokyo, before he decided medicine was how he could directly help others who needed it the most. He attended the University of Pennsylvania where he developed a passion for health disparities, social justice and community medicine in West Philadelphia. As a medical student, he founded the nationally-recognized Cut Hypertension Program (www.cuthypertension.org), a blood pressure screening, education and referral program partnered with African American barbershops. He completed residency and chief residency at UCSF prior to joining the Stanford faculty and Stanford-Intermountain Fellowship in Population Health, Delivery Science, and Primary Care.
Dr. Taylor is a family physician, researcher, implementer, activist and educator. He is excited about the potential for innovative care models, financing and technology to improve the health of underserved populations. He is also interested in HIV primary care, mentoring black men of color in medicine and medical education in community clinics. In addition to his primary care practice at Stanford Family Medicine, Dr. Taylor provides HIV, MAT and Hep C treatment at the Roots Community Health Center in East Oakland where he also leads the community health navigator program for complex care patients.
For fulfillment outside of medicine, he loves being a new dad, plays the violin, travels, spends time outdoors and enjoys cooking with friends and family.
For more information on The Cut Hypertension Program, please visit www.cuthypertension.org; IG - @cuthypertensionprogram; FB ? The Cut Hypertension Program -
Melinda L. Telli, M.D.
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
